An asymmetric synthesis of the macrolide antibiotic (-)-A26771B (1) has been developed wherein the stereochemistries at its C-5 and C-15 centres were installed using an (R)-BINOL-catalyzed allylation and a lipase-catalyzed acylation respectively. Acrylation at the C-15 centre under Mitsunobu conditions followed by a ring closing metathesis provided the macrocylic skeleton, which was suitably functionalized to obtain (-)-1. The biological assay of the antibiotic and two of its precursors suggested that presence of the γ-oxo moiety and the succinate function in (-)-1 were detrimental to its antibacterial activity.
The macrolides belonging to the polyketide class of natural products are of wide occurrence in nature and valued for their bacteriostatic activities [1a-1b] . The 16-membered lactone, (-)-A26771B (1), containing a -oxygenated ,-unsaturated carboxylate moiety, isolated from the fungus Penicillium turbatum showed moderate activity against the gram-positive bacteria, mycoplasma, and fungi [2] . In view of its structural complexity, several racemic [3a-3h] and enantioselective syntheses of 1 have been reported [4a-4h] . Most of the reported syntheses of (-)-1 were targeted to its advanced intermediate 1a and/ or followed the known procedure [4a] of converting 1a to (-)-1. The chemical structures of (-)-1 and 1a are shown in Figure 1 .
Earlier, we had reported a chemoenzymatic synthesis of (-)-1 using lipase-catalyzed acylation reactions [4h] . However, like some of the previously reported syntheses of (-)-1 [4], our chemoenzymatic approach also involved introduction of the unnecessary C(4)-hydroxyl group and its differentiation from other hydroxyl groups. These limitations prompted us to develop an alternative expedient synthesis of (-)-1. In addition, we also studied the antimicrobial property of (-)-1 and two of its precursors, 1a and 11. The synthesis and bioevaluation results are presented in this paper.
Synthesis:
The synthesis (Scheme 1) commenced from the alcohol (S)-3 (98% ee) synthesized as reported previously [4h] . The alcohol (S)-3 was silylated to furnish 4. Dihydroxylation of its alkene function gave the diol 5, which was converted to the aldehyde 6 by NaIO 4 cleavage. For installing the other stereogenic center, we preferred an asymmetric InCl 3 -mediated allylation [6] of the aldehyde 6 with allyl(n-Bu) 3 Sn in the presence of (R)-BINOL and activated 4Å molecular sieves in CH 2 Cl 2 to obtain the alcohol 7 as a single diastereomer (based on isolation) with good yield (88%). The carbinol function in 7 was protected with 3,4-dihydropyran (DHP) to furnish 8. This was desilylated to furnish the alcohol 9, which was subsequently esterified with acrylic acid under Mitsunobu conditions to obtain the acrylate 10. A ring closing metathesis (RCM) [7a-7b] of 10 in the presence of Grubbs' II catalyst in refluxing CH 2 Cl 2 furnished the desired macrolide E-11 (J-H-2 olefinic = 15.6 Hz) in 65% yield. Following a reported method [3f], compound 11 was converted to the -oxo compound 12 via a SeO 2 -catalyzed allylic oxidation. Compound 12 was converted to (-)-1 by depyranylation followed by succinoylation of the crude product [4h]. The spectral data of the synthesized 1 were in conformity with its structure and corresponded well with the reported values [8] .
Anti-microbial studies: In vitro antibacterial activities of (-)-1, its advanced precursor 1a and compound 11 were examined by the spread plate technique, because compound 1a would provide information on the effects of succinate moiety as well as the C(4)-hydroxyl group on the anti-microbial property of (-)-1, whereas compound 11 would decipher the role of the -oxo moiety in the biological activity. All the experiments were carried out three times with similar results and the values are mean ± S. D. Control experiments were carried out under similar condition by using ampicillin and ciprofloxacin for antibacterial activity as standard drugs. The zones of growth inhibition around the disks were measured after 18 to 24 h of incubation at 37°C for bacteria and 48 to 96 h for fungi at 28°C.
Overall, a concise and efficient enantioselective synthesis (10 steps and 16.6% overall yield) of (-)-1 has been developed starting from (S)-3. Considering the synthesis of (S)-3 (84% yield) from commercially available bromide 2 in 4-steps [4h], the overall yield amounts to ~14% for (-)-1 from the bromide 2 in 14-steps. It is an improvement compared to some of the earlier total syntheses which employed expensive chiral pool materials/reagents like (S)-epichlorohydrin [4e] and AD-mix α [4c], yet furnished (-)-1 in 6.3% and 4.1% overall yields respectively. By far the best synthesis (-)-1 was accomplished in 11 steps in 17% overall yield [4g], which is comparable to that of the present one. However, the yield and additional steps required for the synthesis of one key crossmetathesis component were omitted [4g]. Moreover, our synthesis offered the additional flexibility of accessing the C-15 epimer of 1.
The advantage of our synthetic strategy arises from incorporating a late stage allylic oxidation instead of generating a hydroxyl function at C(4) and differentiating it for selective oxidation.
Experimental
General: The chemicals (Fluka and Lancaster) were used as received. Other reagents were of AR grade. All anhydrous reactions were carried out under an Ar atmosphere, using freshly dried solvents. The organic extracts were dried over anhydrous Na 2 (S)-12-tert-Butyldiphenylsilyloxytridec-1-ene (4): To a stirred and cooled (0 o C) solution of the mixture of (S)-3 (4.24 g, 21.38 mmol), imidazole (2.18 g, 32.07 mmol) and DMAP (10 mol%) in CH 2 Cl 2 (20 mL) was dropwise added TBDPSCl (6.6 mL, 25.66 mmol). After stirring the mixture for 7 h at room temperature, it was poured into ice-cold H 2 O (20 mL), the organic layer separated and the aqueous portion extracted with CHCl 3 (3 × 10 mL). The combined organic extracts were washed with H 2 O (2 × 10 mL) and brine (1 × 5 mL), and dried. Removal of solvent in vacuo followed by purification of the residue by column chromatography (silica gel, 0-5% EtOAc/hexane) afforded pure 4 (8.9 g, 96%) as a colorless oil. 11 mmol) in acetone-H 2 O (9:1, 50 mL) was added OsO 4 (0.249 g, 0.98 mmol) in tert-BuOH (6 mL). After consumption of 4 (cf. TLC, 10 h), the reaction mixture was treated with aqueous saturated Na 2 SO 3 and stirred for 1 h. The organic layer was separated and the aqueous portion extracted with EtOAc (3 ×100 mL). The combined organic extracts were washed with H 2 O (2 ×30 mL) and brine (1× 10 mL), dried and concentrated in vacuo. The residue was purified by column chromatography (silica gel, 0-40% EtOAc/hexane) to afford pure 5 (9.0 g, 98%) as a colorless oil. [ 91 mmol) in MeCN-H 2 O (3:2, 15 mL) was added NaIO 4 (2.10 g, 9.81 mmol). After stirring for 2 h, the mixture was concentrated in vacuo, the residue taken in EtOAc (30 mL) and washed successively with H 2 O (1 × 10 mL), aqueous 10% NaHSO 3 (1 × 10 mL), H 2 O (2 × 10 mL) and brine (1 × 5 mL), and dried. Solvent removal furnished the pure aldehyde 6 (2.1 g, 92%) as a colorless oil.
[α] D 24 : -14.6 (c 1.14, CHCl 3 ).
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Natural Product Communications Vol. 2 Cl 2 (10 mL) was added (R)-BINOL (0.281 g, 0.98 mmol) followed by molecular sieves 4Å (12 mg). After 2 h, allyl(n-Bu) 3 Sn (2.8 mL, 8.94 mmol) was added, the mixture stirred for 10 min, cooled to -78 o C and 6 (1.96 g, 4.47 mmol) in CH 2 Cl 2 (10 mL) added. After stirring for 4 h at -78 o C and for 8 h at room temperature, the mixture was treated with aqueous saturated NaHCO 3 and extracted with CHCl 3 (3 × 10 mL). The organic layer was washed with H 2 O (2 × 10 mL) and brine (1 × 5 mL), and concentrated in vacuo to get a residue, which on column chromatography (silica gel, 0-10% EtOAc/hexane) furnished pure 7 (1.9 g, 88%) as a colorless oil. 
(4S,14S)-14-tert-Butyldiphenylsilyloxy-4 tetrahydropyranyloxypentadec-1-ene (8):
A mixture of 7 (1.43 g, 2.97 mmol), DHP (0.4 mL, 4.46 mmol) and PPTS (catalytic) in CH 2 Cl 2 (20 mL) was stirred for 4 h at room temperature. The mixture was poured into ice-cold aqueous 10% NaHCO 3 (20 mL), the organic layer separated and the aqueous portion extracted with CHCl 3 (3 × 10 mL). The combined organic extracts were washed with H 2 O (2 × 10 mL) and brine (1 × 10 mL), and dried. Removal of solvent in vacuo followed by purification of the residue by column chromatography (silica gel, 0-5% EtOAc/hexane) afforded pure 8 (1.56 g, 93%) as colorless oil. 69 mmol) in THF (10 mL) was added Bu 4 NF (5.4 mL, 5.38 mmol, 1 M in THF). After stirring for 4 h, the mixture was concentrated in vacuo, the residue taken in EtOAc (20 mL) and the combined organic extracts washed with H 2 O (1 × 5 mL) and brine (1 × 5 mL), and dried. The residue was purified by column chromatography (silica gel, 0-30% EtOAc/hexane) to afford pure 9 (810 mg, 92%) as a colorless oil.
[ 80 mmol) and acrylic acid (0.26 mL, 3.74 mmol) in THF (15 mL) was dropwise added DIAD (0.55 mL, 2.80 mmol). After stirring the mixture for 12 h at room temperature, it was poured into ice-cold H 2 O (20 mL), the organic layer separated and the aqueous portion extracted with EtOAc (3 ×10 mL). The combined organic extracts were washed with H 2 O (2 ×10 mL) and brine (1 ×5 mL), and dried. Solvent removal in vacuo followed by column chromatography (silica gel, 0-30% EtOAc/hexane) of the residue gave pure 10 (557 mg, 78%) as a colorless oil. Growth and inhibition assay of bacteria: The bacteria were grown in nutrient broth (peptone -5 g/L, meat extract -1 g/L, yeast extract -2 g/L, sodium chloride -5 g/L) or nutrient agar (nutrient broth with 1.5 % w/w agar) as per the requirement. Overnight grown bacteria were diluted (1:100) in nutrient broth and grown fresh at 37 o C for 2-3 h. Mid-exponential-phase bacterial culture (OD 600 0.3-0.5) was exposed to two different concentrations (100 and 200 µg/mL) of the test compounds for 18 h at 37 o C. Control experiments were carried out under similar condition with ampicillin and ciprofloxacin (each, 10 and 100 µg/mL). The number of viable bacteria in each sample was quantified by enumerating them by spread plate technique. Briefly, the different samples were diluted in sterile saline and 0.1 mL of each dilution was spread on freshly prepared sterile nutrient agar plates in triplicate. After incubation at 37 o C for 48 h, the number of colony forming units, representing the actual viable number of bacteria were counted. The number of bacterial cells in the untreated sample was taken as 100% viability and the reduction in viability in the treated samples are expressed as percentage of the untreated sample.
Supplementary data:
1 H and 13 C NMR spectra of all the compounds can be found in the online version.
